Neurocrine Biosciences NBIX Earnings Call Transcripts

NASDAQ NBIX
$174.41 +5.27 (+3.12%)
At close: Nov 11, 2026 · 4:00 PM EST
17 earnings calls on file for Neurocrine Biosciences, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Neurocrine Biosciences Q3 2026 Earnings Call

Nov 2, 2026 8,755 words · 38 min read
  • Todd TushlaVice President of Investor Relations
  • Kyle GanoChief Executive Officer
  • Matthew AbernethyChief Financial Officer
  • Eric BenevichChief Commercial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Neurocrine Biosciences Earnings Call Transcripts

Calls17
LatestNov 2, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2022

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 17 Neurocrine Biosciences transcripts Register to get access to Neurocrine Biosciences’s earnings call transcripts.